28 results
8-K
EX-99.1
DYAI
Dyadic International Inc., DE
14 May 24
Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
4:47pm
of non-pharmaceutical applications and commercial use.
Cell Culture Media Products
In March 2024, the Company executed a term sheet with a large global … , the Company entered into a co-promotion agreement with Biftek Co. for the promotion of growth media supplement for cell culture.
The Company
8-K
EX-99.1
DYAI
Dyadic International Inc., DE
28 Mar 24
Dyadic Reports 2023 Full Year Results and Recent Company Progress
4:07pm
of recombinant serum albumin initially for diagnostic and cell culture applications
Announced strategic partnership to develop affordable rabies … and large-scale manufacture of proteins at low cost in a wide range of non-pharmaceutical applications and commercial use.
Cell Culture Media Products
8-K
EX-99.1
DYAI
Dyadic International Inc., DE
8 Nov 23
Dyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
4:09pm
albumin and other cell culture proteins and enzymes
Cash and investment grade securities of $8.2 million as of September 30, 2023
Financial results … analytical results towards commercialization and prospective licensing opportunities.
The Company is continuing its development cell culture media
8-K
EX-99.1
j2e96nrk
29 Mar 23
Dyadic Reports 2022 Year End Results and Recent Company Progress
4:32pm
8-K
EX-99.1
sotrz pgv
10 Nov 22
Dyadic Reports Third Quarter 2022 Financial Results and Highlights Recent Company Developments
4:06pm
8-K
EX-99.2
n3rpi eyz4x4od
18 Mar 20
Other Events
5:06pm
8-K
EX-99.2
vlrc0 vz0iz5eoq4rt
24 Feb 20
Dyadic Announces New Milestone
9:29am
8-K
EX-99.2
aicvpezeisk
25 Nov 19
Dyadic Announces Achieving Human Like Glycan Structures
4:11pm
10-K
xn9avp3 7ft1uk4i
27 Mar 19
Annual report
4:30pm
10-12G/A
k92h1jm5xw3 t5jw8
9 Oct 14
Registration of securities (amended)
12:00am
10-12G/A
EX-10.14
lr0i0sro1f7t30xywl
16 Sep 14
Registration of securities (amended)
12:00am